RxDoctor Payments DataLook up a doctor →

Hermenegildo Angeles, MD

Geriatric Medicine · Daly City, CANPI 1396712303

Payments from drug & device makers

$18,328in general payments, 2019–2025

Across 612 payments — averaging $29.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$9K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$910
  • Novo Nordisk$771
  • Merck$759
  • E.r. Squibb & Sons, L.L.C.$670
  • Amgen$514
  • plus $6K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson188$9,125
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)42$910
Novo Nordisk41$771
Merck36$759
E.r. Squibb & Sons, L.L.C.29$670
Amgen(2 entities)24$514
Pfizer18$424
GSK16$361
Novartis12$355
AstraZeneca18$354
Lilly USA, LLC14$297
Boehringer Ingelheim12$266
Arbor Pharmaceuticals, Inc.24$265
Bayer9$257
Teva Pharmaceuticals USA, Inc.6$256
Esperion Therapeutics, Inc.9$224
Chiesi USA, Inc.13$208
Amarin Pharma, Inc.8$179
Neurocrine Biosciences, Inc.6$176
Sanofi-aventis U.S. LLC9$165
AbbVie(2 entities)7$152
Biogen7$142
Mylan Specialty L.p.5$129
ANI Pharmaceuticals, Inc.3$112
Astellas Pharma US Inc5$109
Biohaven Pharmaceutical Holding Company Ltd.3$81
Dexcom, Inc.4$79
Sunovion Pharmaceuticals Inc.5$70
Nestle Healthcare Nutrition Inc.3$64
Hikma Pharmaceuticals USA3$58
Aimmune Therapeutics, Inc.2$53
Agepha Pharma FZ LLC2$49
Kowa Pharmaceuticals America, Inc.2$46
Scilex Pharmaceuticals Inc.2$42
Medicomp Inc2$41
Forte Bio-pharma LLC1$41
Otsuka Pharmaceutical Development & Commercialization, Inc.2$36
Exact Sciences1$35
Vertex1$34
Philips North America LLC1$33
Kiniksa Pharmaceuticals International, PLC1$32
Organogenesis Inc.1$28
Medtronic1$27
Alnylam Pharmaceuticals Inc.1$27
Boston Scientific1$27
Corcept Therapeutics1$26
Lexicon Pharmaceuticals, Inc.1$25
Edwards Lifesciences1$25
Avanir Pharmaceuticals, Inc.1$22
Daiichi Sankyo Inc.1$21
Regeneron Healthcare Solutions, Inc.1$21
Eisai Inc.1$21
Genentech USA, Inc.1$20
Lundbeck LLC1$19
Kiniksa Pharmaceuticals, Ltd.1$17
Biodelivery Sciences International, Inc.1$16
Smith+Nephew1$15

How this compares

$18,328 in reported general payments places this provider in the 95th percentile of 494 geriatric medicine providers in California.

See all geriatric medicine providers in California

Medicare billing

Part B allowed, 2024
$271,126
Medicare patients
228
Services billed
2,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other geriatric medicine in Daly City

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →